welcome
CNBC

CNBC

Health

Health

Trump drops Biden's proposal for Medicare to cover obesity drugs like Wegovy and Zepbound

CNBC
Summary
Nutrition label

81% Informative

President Donald Trump dropped a Biden administration proposal to have Medicare cover obesity drugs, including popular GLP-1 treatments such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound .

But the Centers for Medicare and Medicaid Services said it may reconsider coverage of those drugs in the future.

The proposal would have significantly expanded access to those drugs to millions of Americans but would have cost the government billions.

VR Score

86

Informative language

88

Neutral language

43

Article tone

formal

Language

English

Language complexity

58

Offensive language

likely offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

Affiliate links

no affiliate links